Abattis Bioceuticals Corp. (ATTBF)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
25,300 - Avg. Volume
0 - Market Cap (intraday)
47,302 - Beta (5Y Monthly) -66.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
www.abattis.com--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Related News
Performance Overview: ATTBF
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATTBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATTBF
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
11.43
Enterprise Value/EBITDA
-1.40
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-15.94%
Return on Equity (ttm)
-28.13%
Revenue (ttm)
356.88k
Net Income Avi to Common (ttm)
-3.04M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
2.4M
Total Debt/Equity (mrq)
1.41%
Levered Free Cash Flow (ttm)
-2.46M